Ahead of the first phase of the COVID-19 vaccination campaign starting January 16, Madhya Pradesh Chief Minister Shivraj Singh Chouhan said on Thursday that the Covishield and Covaxin vaccines were safe and that there were no difference between the two.
“Covaxin and Covishield have both been properly tested. Our scientists tested them on all parameters and only then was it decided to use them. Both vaccines are safe and there is no difference between the two. Both will build immunity and antibodies, “said the chief minister.
He added that the antibodies would not develop immediately after the vaccination. The second dose will be given 28 days after the first dose and 14 days after the antibodies will develop. Two doses of vaccine are needed.
The Center planned to vaccinate about 3 lakhs of health workers at 2,934 session sites on the first day of the vaccination campaign.
Two COVID-19 vaccines – Covishield and Covaxin – have received emergency use authorization after a high-level meeting going through the safety and immunogenicity established through a well-prescribed regulatory process.
These vaccines can cost between 200 and 295 rupees in India.